Journal of applied microbiology · 2026
Peptoid-based antimicrobial strategies against polymyxin-resistant Gram-negative bacteria.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mishra Shyam Kumar, Shen Jiawei, Akter Tanzina, Tigabu Abiye, Urmi Umme Laila, Damtie Meseret Alem, Mekonen Elias Shiferaw, Kuppusamy Rajesh, Sørensen Kristian, Lin Jennifer S, Wong Edgar H H, Hui Alex, Barron Annelise E, Willcox Mark
Аннотация
AIMS: Polymyxins remain the mainstay antibiotic for the treatment of infections caused by multidrug-resistant bacteria. However, with the increase in the use of polymyxins, the simultaneous rise of polymyxin-resistance cases has been another global threat, necessitating the need for novel therapeutic strategies. This work aimed to evaluate the antibacterial activity of cationic peptoids against polymyxin-resistant bacteria of global priority.
METHODS AND RESULTS: Three paired polymyxin-sensitive/polymyxin-resistant strains were included, along with two clinical isolates and one reference strain. Out of nine cationic peptoids, TM8 showed the most potent activity against the polymyxin-resistant bacteria with a geometric mean minimum inhibitory concentration (MIC) of 15.6 μg mL-1. The MIC of TM8 was 2-fold higher in polymyxin-resistant cases. TM8 synergized with colistin, rifampicin, and ciprofloxacin in polymyxin-resistant bacteria with reductions in MIC of antibiotics ranging from 8- to 64-fold. Enterobacter cloacae did not develop resistance to TM8 upon repeated subpassage at its sub-MIC, whereas it evolved to resist ciprofloxacin by sixty-four-fold under the same conditions. A concentration-dependent membrane-disruptive potential activity was noted in flow cytometry using live-dead staining. The impact of monovalent cations was small (≤2-fold change), while in the presence of divalent cations, the MIC of TM8 increased up to 4-fold.
CONCLUSION: This study presents TM8 as a potential candidate antimicrobial against polymyxin-resistant bacteria. Further studies are recommended focusing on safety, pharmacokinetics, and pharmacodynamics of this compound.
METHODS AND RESULTS: Three paired polymyxin-sensitive/polymyxin-resistant strains were included, along with two clinical isolates and one reference strain. Out of nine cationic peptoids, TM8 showed the most potent activity against the polymyxin-resistant bacteria with a geometric mean minimum inhibitory concentration (MIC) of 15.6 μg mL-1. The MIC of TM8 was 2-fold higher in polymyxin-resistant cases. TM8 synergized with colistin, rifampicin, and ciprofloxacin in polymyxin-resistant bacteria with reductions in MIC of antibiotics ranging from 8- to 64-fold. Enterobacter cloacae did not develop resistance to TM8 upon repeated subpassage at its sub-MIC, whereas it evolved to resist ciprofloxacin by sixty-four-fold under the same conditions. A concentration-dependent membrane-disruptive potential activity was noted in flow cytometry using live-dead staining. The impact of monovalent cations was small (≤2-fold change), while in the presence of divalent cations, the MIC of TM8 increased up to 4-fold.
CONCLUSION: This study presents TM8 as a potential candidate antimicrobial against polymyxin-resistant bacteria. Further studies are recommended focusing on safety, pharmacokinetics, and pharmacodynamics of this compound.